Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In this study, we assessed the sensitivity of myeloma cells to the oncolytic
measles
virus (MV) in relation to
p53
using 37 cell lines and 23 primary samples. We showed that infection and cell death were correlated with CD46 expression, which was associated with
TP53
status;
TP53
abn
cell lines highly expressed CD46 and were preferentially infected by MV when compared with the
TP53
wt
cell lines (
P
= .046 and
P
= .045, respectively). Infection of myeloma cells was fully dependent on CD46 expression in both cell lines and primary cells. In the
TP53
wt
cell lines, but not the
TP53
abn
cell lines, activation of the
p53
pathway with nutlin3a inhibited both CD46 expression and MV infection, while
TP53
silencing reciprocally increased CD46 expression and MV infection. We showed using a
p53
chromatin immunoprecipitation assay and microRNA assessment that
CD46
gene expression was directly and indirectly regulated by
p53
. Primary myeloma cells overexpressed CD46 as compared with normal cells and were highly infected and killed by MV. CD46 expression and MV infection were inhibited by nutlin3a in primary
p53
-competent myeloma cells, but not in
p53
-deficient myeloma cells, and the latter were highly sensitive to MV infection. In summary, myeloma cells were highly sensitive to MV and infection inhibition by the
p53
pathway was abrogated in
p53
-deficient myeloma cells. These results argue for an MV-based clinical trial for patients with
p53
deficiency.
...
PMID:p53 regulates CD46 expression and measles virus infection in myeloma cells. 3053 Jul 76
<< Previous
1
2